WE Communications launches scientific engagement service

PR agency WE Communications has set up a new scientific engagement and medical education offering and recruited Terry Bradley and Ben Fisher to lead it.

The duo, who are based in the UK, will be directors at WE Communications and tasked with driving new business for the service and supporting the agency’s clients at a country, EMEA and global level.

Bradley (pictured above right) has worked in healthcare communications for over 30 years, starting in scientific and medical publishing, where he worked across clinical review and life science journals. After three years at The Lancet, he moved agency-side, most recently serving as managing director at Health Unlimited.

Meanwhile, with more than 20 years of experience in health and scientific communications, Fisher (pictured above left) has worked with agencies including WPP and Omnicom, and smaller health offers, including in educational and digital roles, and he moved to WE Communications from Health Unlimited, where he was a director.

Fisher said of WE Communications’ new service launch: “Scientific engagement enables our clients to tell the human story behind the data. Behavioural science will be at the heart of everything we do and all our programmes will be designed with the purpose of illustrating the positive impact of our clients’ innovations in this unprecedented time.”

Bradley added: “Now more than ever, pharma companies need help understanding the role technology can play in their ‘new normal’ and how to effectively deploy it to increase audience engagement and understanding.

“I look forward to partnering with clients to navigate this rapidly changing environment, extending the agency’s already-established data-driven, creative communications offer to scientific engagement and medical education.”

Catherine Devaney, head of health and UK deputy managing director at WE Communications, said: “COVID-19 has triggered a ‘vital revolution’ in the way pharmaceutical companies need to engage with their stakeholders.

“The pandemic has been a catalyst for speeding up the use of technology by pharma to quickly reach and educate audiences, especially given the demand for rapid progress in resolving this health crisis.”

WE Communications’ new service will cover digital engagement, partnerships with the clinical community, scientific narrative and strategy development.